Suppr超能文献

完全切除的N0期非小细胞肺癌:影响长期生存的预后因素

Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival.

作者信息

Tantraworasin Apichat, Saeteng Somcharoen, Lertprasertsuke Nirush, Arayawudhikule Nuttapon, Kasemsarn Choosak, Patumanond Jayanton

机构信息

General Thoracic Unit, Department of Surgery, Faculty of Medicine, Chiang Mai University Hospital, Chiang Mai 50200, Thailand.

出版信息

ISRN Surg. 2013 Aug 29;2013:175304. doi: 10.1155/2013/175304. eCollection 2013.

Abstract

Background. Although early stage non-small cell lung cancer (NSCLC) has an excellent outcome and correlated with good long-term survival, up to 15 percent of patients still relapse postoperatively and die. This study is conducted to identify prognostic factors that may affect the long-term survival in completely resected N0 NSCLC. Methods. Medical records of 124 patients with completely resected N0 NSCLC were retrospectively reviewed. Prognostic factors affecting long-term survival were analyzed by the Kaplan-Meier method and Cox proportional hazards analysis. Results. Overall five-year survival rate was 48 percent. Multivariable analysis revealed stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases as significant prognostic factors affecting long-term survival. The hazard ratio (HR) of tumor necrosis, tumor recurrence, brain metastasis, adrenal metastases, and skin metastases was 2.0, 2.3, 7.6, 4.1, and 8.3, respectively, and all P values were less than 0.001. Conclusions. Our study shows stage of disease, tumor necrosis, tumor recurrence, brain metastasis, adrenal metastasis, and skin metastasis as the independent prognostic factors of long-term survival in pathological N0 NSCLC. Early stage NSCLC patients without nodal involvement or presented with tumor necrosis should benefit from adjuvant chemotherapy, and sites of metastasis could predict the long-term survival as described.

摘要

背景。尽管早期非小细胞肺癌(NSCLC)预后良好且与长期生存相关,但仍有高达15%的患者术后复发并死亡。本研究旨在确定可能影响完全切除的N0期NSCLC患者长期生存的预后因素。方法。回顾性分析124例完全切除的N0期NSCLC患者的病历。采用Kaplan-Meier法和Cox比例风险分析评估影响长期生存的预后因素。结果。总体五年生存率为48%。多变量分析显示疾病分期、肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移是影响长期生存的重要预后因素。肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移的风险比(HR)分别为2.0、2.3、7.6、4.1和8.3,所有P值均小于0.001。结论。我们的研究表明,疾病分期、肿瘤坏死、肿瘤复发、脑转移、肾上腺转移和皮肤转移是病理N0期NSCLC患者长期生存的独立预后因素。无淋巴结受累或存在肿瘤坏死的早期NSCLC患者应从辅助化疗中获益,转移部位可如所述预测长期生存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e93c/3773441/5e7db7ade002/ISRN.SURGERY2013-175304.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验